Wen Jie Zhang

Wen Jie Zhang

59 ans
Health Technology
Consumer Services
Electronic Technology

Profil

Wen Jie Zhang is Co-President & Co-CEO-Innovative Medicines at Shanghai Fosun Pharmaceutical (Group) Co., Ltd. since 2025.
Holds the position of President, Chief Executive Officer & Director at Shanghai Henlius Biopharmaceuticals Co., Ltd. since 2020.
Serves as Executive President & Co-Chief Executive Officer at Fosun Pharma Group Co. Ltd. Chairman of Shanghai Henlius Biotech, Inc. since 2023.
Chairman of Fosun Kite Biotechnology Co., Ltd. Director, Chief Executive & Financial Officer at Hengenix Biotech, Inc. Non-Independent Non-Executive Director at Gland Pharma Ltd. since 2024.
Education includes an undergraduate degree from Shandong University conferred in 1990 and an MBA from Yale School of Management.

Postes actifs de Wen Jie Zhang

SociétésPosteDébut
SHANGHAI HENLIUS BIOTECH, INC. Président 30/11/2021
GLAND PHARMA LIMITED Directeur/Membre du Conseil 30/08/2024
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. President 01/07/2023
Shanghai Henlius Biopharmaceuticals Co. , Ltd.
Directeur Général -
Directeur Général -
Président -
Fosun Pharma Group Co. Ltd.
Directeur Général -

Formation de Wen Jie Zhang

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

64

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Shanghai Henlius Biopharmaceuticals Co. , Ltd.

Electronic Technology

Fosun Pharma Group Co. Ltd.

  1. Bourse
  2. Insiders
  3. Wen Jie Zhang
🔇